ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.

ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.

PR Newswire

SUNNYVALE, Calif., Oct. 21, 2013

SUNNYVALE, Calif., Oct. 21, 2013 /PRNewswire/ -- ARRAYit Corporation (OTCQB:
ARYC) announces that the company has shipped its proprietary microarray life
sciences products to Illumina Inc. (NASDAQ: ILMN), a developer, manufacturer
and marketer of life science tools and integrated systems for the analysis of
genetic variation and biological function using its proprietary bead array and
solid phase sequencing technologies to empower DNA microarray and next
generation sequencing (NGS) applications.

A microarray technology leader, Illumina was founded in 1998. The company is
based in San Diego, California. Illumina's DNA sequencing platform is used to
sequence an impressive 90% of all human DNA worldwide.

ARRAYit's patented contact printing platform and consumables empower a wide
range of synergistic applications with Illumina including multi-patient
genotyping, high-sensitivity gene expression analysis, serum-based protein
diagnostics, affordable consumer testing, and many others. Over 100 scientific
publications available on-line feature ARRAYit and Illumina technology
simultaneously, which highlights the complementarity of the two patented

Illumina had $1.1 billion in total revenue in fiscal 2012. ARYC product sales
to Illumina will book as revenue and earnings in the fourth quarter of 2013.

About ARRAYit Corporation

ARRAYit Corporation is a Sunnyvale, California-based company leading and
empowering the genetic, research, pharmaceutical, and diagnostic communities
through the discovery, development, and manufacture of proprietary life
science technologies and consumables for disease prevention, treatment and
cure. The company's innovative products and services help scientists and
clinicians explore the human genome as well as the genomes of plants and
animals. ARRAYit's products are used by every major research center in the

About Liston Street Pulse

Liston Street Pulse is a leading provider of financial research. The company
has significant expertise in U.S. listed small cap and micro-cap stocks.
Subscribe here to read more about ARYC, including CEO interviews.

Safe Harbor Statement

Except for historical information contained herein, statements made in this
release that constitute forward-looking statements are based on currently
available information, involve certain risks and uncertainties and the Company
assumes no responsibility to update any such forward-looking statement. The
following factors, among others, may cause actual results to differ materially
from the results suggested in the forward-looking statements. Risks that may
result from changes in the Company's business operations; our ability to keep
pace with technological advances; significant competition in the biomedical
business; our relationships with key suppliers and customers; quality and
consumer acceptance of newly introduced products; market volatility;
non-availability of product; excess inventory; price and product competition;
new product introductions, the outcome of our legal disputes; the possibility
that the review of our prior filings by the SEC may result in changes to our
financial statements; and the possibility that stockholders or regulatory
authorities may initiate proceedings against ARRAYit and/or our officers and
directors as a result of any restatements. Risk factors associated with our
business, including some of the facts set forth herein, are detailed in the
Company's Form 10-K for the fiscal year ended December 31, 2012 and Form 10-Q
for the fiscal first quarter ended March 31, 2013, Form 10-Q for the fiscal
second quarter ended June 30, 2013.

SOURCE ARRAYit Corporation

Contact: Investor Contact: Shas Dey, 201 762 3684,
Press spacebar to pause and continue. Press esc to stop.